34:03PodcastThomas J. Bollyky
Archive
721 results
34:03PodcastResearchers Call for Allowing Importation, Reciprocal Approvals for Some Generic Drugs
Regulatory Focus
Featuring Thomas J. Bollyky- Expert TakeBy Thomas J. Bollyky
- Featuring Thomas J. Bollyky
Tillerson's rhetoric didn't match reality on global health
Washington Post
Featuring Thomas J. Bollyky- By Benn Steil, Michael Froman, Edward Alden, Thomas J. Bollyky and Shannon K. O'Neil
More Taxes, Less Death?
The Atlantic
Featuring Thomas J. Bollyky- Featuring Thomas J. Bollyky
By Thomas J. Bollyky and Amanda Shendruk- Expert Take
Lower-Income Countries That Face The Most Rapid Shift In Noncommunicable Disease Burden Are Also The Least Prepared
Health Affairs
By Thomas J. Bollyky, Tara Templin, Matthew Cohen and Joseph L. Dieleman
Featuring Thomas J. Bollyky
Featuring Thomas J. Bollyky- Expert TakeBy Thomas J. Bollyky
- Expert TakeBy Thomas J. Bollyky
- Expert Take
Can Drug Importation Address High Generic Drug Prices?
Brookings Institution
By Thomas J. Bollyky and Aaron S. Kesselheim What's on the table in a NAFTA negotiation
Los Angeles Times
Featuring Thomas J. BollykyHow Trump Could Make NAFTA Better But Probably Won't
The New Yorker
Featuring Thomas J. Bollyky- Expert Take
Trade, Social Preferences, and Regulatory Cooperation
Journal of International Economic Law
By Thomas J. Bollyky and Petros C. Mavroidis How Donald Trump can sidestep Congress on NAFTA
The Globe and Mail
Featuring Thomas J. Bollyky- Featuring Thomas J. Bollyky
- Featuring Thomas J. Bollyky
- Featuring Thomas J. Bollyky
- Expert Take
The Role of Science, Technology, Innovation, and Partnerships in the Future of USAID
The National Academies of Sciences, Engineering, and Medicine
By Thomas J. Bollyky